Singapore markets open in 5 hours 50 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,301.57 +54.89 (+1.05%) Dow
39,842.93 +284.82 (+0.72%) Nasdaq
16,733.08 +221.90 (+1.34%) Bitcoin USD
65,434.39 +4,044.26 (+6.59%) CMC Crypto 200
1,378.53 +110.58 (+8.72%)
Lotus Pharmaceutical Co., Ltd. (1795.TW)
Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
At close: 01:30PM CST
| Previous close | 283.00 |
| Open | 284.50 |
| Bid | 281.00 x N/A |
| Ask | 281.50 x N/A |
| Day's range | 278.50 - 288.00 |
| 52-week range | 205.00 - 349.50 |
| Volume | |
| Avg. volume | 6,820,246 |
| Market cap | 74.845B |
| Beta (5Y monthly) | 0.52 |
| PE ratio (TTM) | 18.65 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.46 (1.20%) |
| Ex-dividend date | 05 Jul 2023 |
| 1y target est | N/A |
- Business Wire
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY® in Multiple Markets Across Asia
BOSTON & TAIPEI, Taiwan, August 10, 2023--Corium, LLC ("Corium"), a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Lotus Pharmaceutical (1795:TT; "Lotus"), a multinational pharmaceutical company, announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY® (donepezil transdermal system), an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
© 2024 Yahoo. All rights reserved.